Mauro Krampera – VJRegenMed https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Wed, 25 Aug 2021 11:23:42 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png Mauro Krampera – VJRegenMed https://mirror.vjregenmed.com 32 32 Respiratory pathology of COVID-19 and potential for MSCs https://mirror.vjregenmed.com/video/0m00kvt0n5u-respiratory-pathology-of-covid-19-and-potential-for-mscs/ Wed, 19 Aug 2020 16:20:19 +0000 http://vjregenmed.devbrandcast.com/video/0m00kvt0n5u-respiratory-pathology-of-covid-19-and-potential-for-mscs/ Mauro Krampera, MD, PhD, of the University of Verona, Verona, Italy, discusses the pathogenesis of COVID-19 and the potential benefit of administrating mesenchymal stromal cells (MSCs) based on outcomes of patients with inflammatory disorders treated using this approach. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

]]>
Functional dosing of MSC-derived extracellular vesicles for the prevention of GvHD https://mirror.vjregenmed.com/video/nhc_n2dz5zg-functional-dosing-of-msc-derived-extracellular-vesicles-for-the-prevention-of-gvhd/ Wed, 19 Aug 2020 16:20:19 +0000 http://vjregenmed.devbrandcast.com/video/nhc_n2dz5zg-functional-dosing-of-msc-derived-extracellular-vesicles-for-the-prevention-of-gvhd/ Mauro Krampera, MD, PhD, of the University of Verona, Verona, Italy, outlines the use of mesenchymal stromal cell (MSC)-derived extracellular vesicles for the prevention of acute graft-versus-host disease (GvHD). This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

]]>